JAGSONPAL PHARMACEUTICALS
Back to Balance Sheet
|
JAGSONPAL PHARMACEUTICALS Last 5 Year Contingent Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹16 Cr | ₹11 Cr | ₹6.09 Cr | ₹7.96 Cr | ₹8.08 Cr |
What is the latest Contingent Liabilities ratio of JAGSONPAL PHARMACEUTICALS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹16 Cr |
| Mar2024 | ₹11 Cr |
| Mar2023 | ₹6.09 Cr |
| Mar2022 | ₹7.96 Cr |
| Mar2021 | ₹8.08 Cr |
How is Contingent Liabilities of JAGSONPAL PHARMACEUTICALS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹16 Cr | 44.14 | |
| Mar2024 | ₹11 Cr | 84.29 | |
| Mar2023 | ₹6.09 Cr | -23.57 | |
| Mar2022 | ₹7.96 Cr | -1.44 | |
| Mar2021 | ₹8.08 Cr | - | |
Compare Contingent Liabilities of peers of JAGSONPAL PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JAGSONPAL PHARMACEUTICALS | ₹1,463.3 Cr | -0.5% | -3.5% | -13.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,711.0 Cr | -0.8% | 3.5% | 14.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,376.0 Cr | -1% | 7.3% | 7.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,655.0 Cr | -0.9% | 10.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹113,979.0 Cr | -2.1% | -1.8% | -6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,204.7 Cr | -5.8% | -13.2% | -7.7% | Stock Analytics | |
JAGSONPAL PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JAGSONPAL PHARMACEUTICALS | -0.5% |
-3.5% |
-13.6% |
| SENSEX | -2.7% |
-0.2% |
-8% |
You may also like the below Video Courses